摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

neolymphostin A

中文名称
——
中文别名
——
英文名称
neolymphostin A
英文别名
neolymphostin;N-[11-amino-6-(3-methoxyprop-2-enoyl)-2,7-diazatricyclo[6.3.1.04,12]dodeca-1(12),2,4,6,8,10-hexaen-9-yl]-2-methylpropanamide
neolymphostin A化学式
CAS
——
化学式
C18H18N4O3
mdl
——
分子量
338.366
InChiKey
OKZVXALNOKYCRL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.82
  • 重原子数:
    25.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    106.67
  • 氢给体数:
    2.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    描述:
    neolymphostin Acopper(ll) sulfate pentahydrate碳酸氢钠sodium ascorbate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.17h, 生成 N-(8-amino-4-(3-(2-(4-(14-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-6,9,12-trioxa-2-azatetradecyl)-1H-1,2,3-triazol-1-yl)ethoxy)-3-methoxypropanoyl)pyrrolo[4,3,2-de]quinolin-6-yl)isobutyramide
    参考文献:
    名称:
    Novel PIKK inhibitor antibody-drug conjugates: Synthesis and anti-tumor activity
    摘要:
    Novel neolymphostin-based antibody-drug conjugate (ADC) precursors were synthesized either through amide couplings between both cleavable and non-cleavable linkers and neolymphostin derivatives, or through Cu(I)-catalyzed acetylene-azide click cycloadditon between non-cleavable linkers and neolymphostin acetal derivatives. These precursors were site-specifically conjugated to cysteine mutant trastuzumab-A114C to provide neolymphostin-based ADCs. Preliminary in vitro data indicated that the corresponding ADCs were active against HER2-expressing tumor cell lines, thus providing a proof-of-concept for using neolymphostin as ADC-based anticancer agents.
    DOI:
    10.1016/j.bmcl.2019.01.009
点击查看最新优质反应信息

文献信息

  • PYRROLO[4,3,2-DE]QUINOLIN-8-AMINE COMPOUNDS AND METHODS OF THEIR PREPARATION AND USE
    申请人:Wyeth LLC
    公开号:EP2340251A1
    公开(公告)日:2011-07-06
  • JP2012500206A
    申请人:——
    公开号:JP2012500206A
    公开(公告)日:2012-01-05
  • US8486961B2
    申请人:——
    公开号:US8486961B2
    公开(公告)日:2013-07-16
  • [EN] PYRROLO[4,3,2-DE]QUINOLIN-8-AMINE COMPOUNDS AND METHODS OF THEIR PREPARATION AND USE<br/>[FR] COMPOSÉS PYRROLO[4,3,2-DE]QUINOLÉIN-8-AMINES ET LEURS PROCÉDÉS DE PRÉPARATION ET D'UTILISATION
    申请人:WYETH CORP
    公开号:WO2010019659A1
    公开(公告)日:2010-02-18
    The present invention relates to compounds of formula (I) methods of their use, processes for their preparation and isolated actinomycetes strains capable of preparing pyrrolo[4,3,2-de]quinolin-8-amine compounds.
  • Novel PIKK inhibitor antibody-drug conjugates: Synthesis and anti-tumor activity
    作者:Dahui Zhou、Jeffrey Casavant、Edmund I. Graziani、Haiyin He、Jeffrey Janso、Frank Loganzo、Sylvia Musto、Nathan Tumey、Christopher J. O'Donnell、Russell Dushin
    DOI:10.1016/j.bmcl.2019.01.009
    日期:2019.4
    Novel neolymphostin-based antibody-drug conjugate (ADC) precursors were synthesized either through amide couplings between both cleavable and non-cleavable linkers and neolymphostin derivatives, or through Cu(I)-catalyzed acetylene-azide click cycloadditon between non-cleavable linkers and neolymphostin acetal derivatives. These precursors were site-specifically conjugated to cysteine mutant trastuzumab-A114C to provide neolymphostin-based ADCs. Preliminary in vitro data indicated that the corresponding ADCs were active against HER2-expressing tumor cell lines, thus providing a proof-of-concept for using neolymphostin as ADC-based anticancer agents.
查看更多